Infant, Premature, Diseases Clinical Trial
— OsciflowOfficial title:
Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants: A Randomized Crossover Trial
Verified date | January 2022 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the effect of non-invasive high frequency oscillations applied via a highflow nasal cannula ('Osciflow') compared to highflow nasal cannula without oscillations (HF) on desaturations and bradycardia in premature infants. It uses a crossover design. Infants are randomized to begin the study with either Osciflow or HF. Both modes are applied for 4 hours. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate, and with a transcutaneous CO2-transducer. Further measurements include respiratory rate and 'Bernese pain scale' evaluated by nursing staff and Electrical Impedance Tomography (EIT) in a subset of patients.
Status | Completed |
Enrollment | 30 |
Est. completion date | November 26, 2021 |
Est. primary completion date | November 26, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Preterm infants born with a gestational age of <35 weeks - >72 hours old - On nCPAP with PEEP 5 mbar and FiO2 <0.3 Exclusion Criteria: - Severe congenital malformations adversely affecting life expectancy |
Country | Name | City | State |
---|---|---|---|
Switzerland | Department of Neonatology, University Hospital Zurich | Zurich |
Lead Sponsor | Collaborator |
---|---|
University of Zurich |
Switzerland,
Rub DM, Sivieri EM, Abbasi S, Eichenwald E. Effect of high-frequency oscillation on pressure delivered by high flow nasal cannula in a premature infant lung model. Pediatr Pulmonol. 2019 Nov;54(11):1860-1865. doi: 10.1002/ppul.24459. Epub 2019 Jul 24. — View Citation
Sivieri EM, Eichenwald E, Bakri SM, Abbasi S. Effect of high frequency oscillatory high flow nasal cannula on carbon dioxide clearance in a premature infant lung model: A bench study. Pediatr Pulmonol. 2019 Apr;54(4):436-443. doi: 10.1002/ppul.24216. Epub 2018 Dec 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Paired difference in the total number of desaturations and bradycardia between Osciflow and HF | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in respiratory rate | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in heart rate | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in fraction of inspired oxygen [FiO2] | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in peripheral oxygen saturation [SpO2] | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in the proportion of time spent with oxygen saturations < 80% | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in the proportion of time spent with heart rates < 80 bpm | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in the number of apneas requiring stimulation | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in transcutaneous CO2 measurements | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in pain assessment using 'Bernese pain scale' | Bernese Pain-Scale for Neonates (BPSN): a 9-item multidimensional pain assessment tool that includes behavioral and physiological indicators. The instrument consists of seven subjective (alertness, crying, consolation, skin color, facial expression, posture, and changes in respiratory rate) and two physiological (i.e. objective) (changes in heart rate and oxygen saturation) indicators. Each item is rated on a four point Likert scale (0, 1, 2, and 3). Higher scores indicate greater pain-related distress, and a total score of 11 or higher is considered to indicate pain. | 180-minute recording periods for each therapy | |
Secondary | Paired difference in end-expiratory lung impedance (EELI) in a subset of patients. | EELI using electrical impedance tomography (arbitrary units per kilogram). | At the end of each intervention period | |
Secondary | Paired difference in regional ventilation distribution in a subset of patients. | Regional ventilation distribution using electrical impedance tomography (arbitrary units per kilogram). | At the end of each intervention period | |
Secondary | Paired difference in Tidal volumes in a subset of patients. | Tidal volumes using electrical impedance tomography (arbitrary units per kilogram). | At the end of each intervention period | |
Secondary | Paired difference in nasal trauma score | Royal Women's Hospital Nasal Integrity and Pressure Chart.
Nasal injury is defined as stage 0-skin intact; stage 1-nonblanchable erythema of intact skin; stage 2-partial thickness skin loss involving epidermis, dermis, or both; stage 3-full thickness skin loss involving damage to or necrosis of subcutaneous tissue; stage 4-full thickness skin loss with extensive destruction, tissue necrosis, or damage to supporting structures. Lowest Score: 0. Highest Score: 4. A higher score indicates more extensive nasal injury. |
At the end of each intervention period | |
Secondary | Paired difference in the rate of pneumothorax | 180-minute recording periods for each therapy | ||
Secondary | Paired difference in reaching 'failure criteria' to stop Osciflow or HF therapy: | Definition of failure criteria
Respiratory rate >90/min for more than 30 minutes Respiratory rate >20/min higher than at the beginning of the study Increase in FiO2 by = 0.25 from baseline for more than 30 minutes Apnea-Score of more than 20/4 hours |
180-minute recording periods for each therapy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05030337 -
Optimising Ventilation in Preterms With Closed-loop Oxygen Control
|
N/A | |
Completed |
NCT02916914 -
Impact of Feeding Interval of Preterms on the Time of Transition From Tube Feeding to Oral Feeding
|
N/A | |
Not yet recruiting |
NCT06335524 -
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
|
N/A | |
Completed |
NCT02391389 -
VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping
|
N/A | |
Completed |
NCT00419588 -
Growth of Airways and Lung Tissues in Premature and Healthy Infants
|
||
Completed |
NCT05217186 -
Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
|
||
Completed |
NCT04886310 -
Peabody Developmental Motor Scale-2 in 0 - 24 Months in Turkey
|
||
Enrolling by invitation |
NCT04478487 -
Novel Human Milk Based Human Milk Fortifier
|
N/A | |
Not yet recruiting |
NCT05592431 -
Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Neonates
|
N/A | |
Enrolling by invitation |
NCT05011071 -
The Alberta BLOOM Premature Child Study
|
||
Completed |
NCT04889846 -
The Effects of SAFE Early Intervention Approach in Premature Infants in Turkey
|
N/A | |
Recruiting |
NCT04064398 -
Evaluation of Gastric Residuals and Feedings Progression
|
N/A | |
Completed |
NCT04500353 -
Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA Trial
|
N/A | |
Completed |
NCT04247308 -
Multi Modal Stimulations in Pre-term Neonates
|
N/A | |
Completed |
NCT03860142 -
Evolution of Food Orality in Children Aged Between 24 and 36 Months: Comparison of the Severity and Specificities of Disorders Between Two Populations of Children, Born Very Prematurely and Born at Term
|
||
Completed |
NCT04234152 -
Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study
|
N/A | |
Terminated |
NCT04641000 -
The Alberta BLOOM Long Term Follow Up Study
|
||
Completed |
NCT04284891 -
Critical Respiratory Diseases in Ex-preterm Infants in PICU
|
||
Completed |
NCT00062452 -
Esophageal Motility and Airway Defenses Among Infants
|
N/A | |
Completed |
NCT00579943 -
Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants
|
N/A |